Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.
White hormonal contraception breast cancer risk contemporary formulations review, lower dose estrogen new synthetic progestin breast cancer risk hormonal contraception, combined oral contraceptive breast cancer relative risk prospective cohort evidence, hormonal patch ring implant breast cancer risk newer delivery methods, 1.2 million Danish women hormonal contraception breast cancer Morch 2017 study, American Journal Lifestyle Medicine 2018 hormonal contraception breast cancer risk, estrogen-progestin contraceptive duration breast cancer risk dose-response relationship, progestin-only pill IUD injectable breast cancer risk versus combined methods, contemporary hormonal contraception low-dose formulations breast cancer evidence, hormonal contraception informed consent breast cancer risk prescribing counseling
PMID 30283254 30283254 DOI 10.1177/1559827618754833 10.1177/1559827618754833
Cite this article
White, N. D. (2018). Hormonal Contraception and Breast Cancer Risk. *American journal of lifestyle medicine*, *12*(3), 224-226. https://doi.org/10.1177/1559827618754833
White ND. Hormonal Contraception and Breast Cancer Risk. Am J Lifestyle Med. 2018;12(3):224-226. doi:10.1177/1559827618754833
White, Nicole D. "Hormonal Contraception and Breast Cancer Risk." *American journal of lifestyle medicine*, vol. 12, no. 3, 2018, pp. 224-226.
Saleh B et al., 2021Breast Cancer Research and Treatment
Purpose: Herein, our purpose was to calculate the 5-year and lifetime risk of breast cancer and to assess new breast cancer potential contributors among Egyptian women utilizing the modified Gail mode...
General OB/GYN > Breast Health > Cancer Risk AssessmentContraception/Comparison > Side Effects > Breast Cancer RiskResearch Methodology > Epidemiology > Cross-Sectional Studies
Mørch LS et al., 2017The New England Journal of Medicine
BACKGROUND: Little is known about whether contemporary hormonal contraception is associated with an increased risk of breast cancer.
METHODS: We assessed associations between the use of hormonal cont...
Contraception/Comparison > Side Effects > Breast Cancer RiskContraception/Comparison > Hormonal Contraception > Combined Oral ContraceptivesContraception/Comparison > Hormonal Contraception > Progestin-Only Methods
Heikkinen S et al., 2015Cancer Causes & Control : CCC
Purpose: Main aim was to estimate the association between use of exogenous hormones and breast cancer (BC) risk in a large population-based survey, and to assess the representativeness and overall val...
Contraception/Comparison > Side Effects > Breast Cancer RiskContraception/Comparison > Intrauterine Devices > Hormone-Releasing IUD SafetyResearch Methodology > Case-Control Study > Validation